Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI
Abstract Background We assessed immunotherapy response in a murine melanoma model using multiparametric magnetic resonance imaging (mpMRI) features with ex vivo immunohistochemical validation. Methods Murine melanoma cells (B16-F10) were inoculated into the subcutaneous flank of n = 28 C57BL/6 mice...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-06-01
|
| Series: | European Radiology Experimental |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41747-025-00597-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691528556969984 |
|---|---|
| author | Maurice M. Heimer Amra Cimic Sandra Kloiber-Langhorst Melissa J. Antons Jennifer Stueckl Heidrun Hirner-Eppeneder Wolfgang G. Kunz Olaf Dietrich Jens Ricke Felix L. Herr Clemens C. Cyran |
| author_facet | Maurice M. Heimer Amra Cimic Sandra Kloiber-Langhorst Melissa J. Antons Jennifer Stueckl Heidrun Hirner-Eppeneder Wolfgang G. Kunz Olaf Dietrich Jens Ricke Felix L. Herr Clemens C. Cyran |
| author_sort | Maurice M. Heimer |
| collection | DOAJ |
| description | Abstract Background We assessed immunotherapy response in a murine melanoma model using multiparametric magnetic resonance imaging (mpMRI) features with ex vivo immunohistochemical validation. Methods Murine melanoma cells (B16-F10) were inoculated into the subcutaneous flank of n = 28 C57BL/6 mice (n = 14 therapy; n = 14 control). Baseline mpMRI was acquired on day 7 at 3 T. The immunotherapy group received three intraperitoneal injections of anti-PD-L1 and anti-CTLA-4 antibodies on days 7, 9, and 11 after inoculation. Controls received a volume equivalent placebo. Follow-up mpMRI was performed on day 12. We assessed tumor volume, diffusion-weighted imaging parameters, including the apparent diffusion coefficient (ADC), and dynamic-contrast-enhanced metrics, including plasma volume and plasma flow. Tumor-infiltrating lymphocytes (TIL; CD8+), cell proliferation (Ki-67), apoptosis (terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling, TUNEL), and microvascular density (CD31+) were assessed in a validation cohort of n = 24 animals for time-matched ex vivo validation. Results An increase in tumor volume was observed in both groups (p ≤ 0.004) without difference at follow-up (p = 0.630). A lower ADC value was observed in the immunotherapy group at follow-up (p = 0.001). Immunohistochemistry revealed higher TUNEL values (p < 0.001) and CD8+ TILs (p = 0.048) following immunotherapy, as well as lower tumor cell Ki-67 values (p < 0.001) and microvascular density/CD31+ (p < 0.001). Conclusion Lower tumor ADC, paired with higher intratumoral expression of CD8+ TIL, was observed five days after immunotherapy, suggestive of early immunological response. Ex vivo immunohistochemistry confirmed the antitumoral efficacy of immunotherapy. Relevance statement Compared to tumor size, diffusion-weighted MRI demonstrated potential for early response assessment to immunotherapy in a murine melanoma model, which could reflect changes in the tumor microenvironment and immune cell infiltration. Key Points No difference in tumor volume was observed between groups before and after therapy. Lower ADC values paired with increased CD8+ TILs were observed following immunotherapy. Ex vivo immunohistochemistry confirmed antitumoral efficacy of anti-PD-L1 and anti-CTLA-4 immunotherapy. Graphical Abstract |
| format | Article |
| id | doaj-art-b523e15bf7924c22932b84a15714b237 |
| institution | DOAJ |
| issn | 2509-9280 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | European Radiology Experimental |
| spelling | doaj-art-b523e15bf7924c22932b84a15714b2372025-08-20T03:20:59ZengSpringerOpenEuropean Radiology Experimental2509-92802025-06-019111310.1186/s41747-025-00597-8Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRIMaurice M. Heimer0Amra Cimic1Sandra Kloiber-Langhorst2Melissa J. Antons3Jennifer Stueckl4Heidrun Hirner-Eppeneder5Wolfgang G. Kunz6Olaf Dietrich7Jens Ricke8Felix L. Herr9Clemens C. Cyran10Department of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichDepartment of Radiology, LMU University Hospital, LMU MunichAbstract Background We assessed immunotherapy response in a murine melanoma model using multiparametric magnetic resonance imaging (mpMRI) features with ex vivo immunohistochemical validation. Methods Murine melanoma cells (B16-F10) were inoculated into the subcutaneous flank of n = 28 C57BL/6 mice (n = 14 therapy; n = 14 control). Baseline mpMRI was acquired on day 7 at 3 T. The immunotherapy group received three intraperitoneal injections of anti-PD-L1 and anti-CTLA-4 antibodies on days 7, 9, and 11 after inoculation. Controls received a volume equivalent placebo. Follow-up mpMRI was performed on day 12. We assessed tumor volume, diffusion-weighted imaging parameters, including the apparent diffusion coefficient (ADC), and dynamic-contrast-enhanced metrics, including plasma volume and plasma flow. Tumor-infiltrating lymphocytes (TIL; CD8+), cell proliferation (Ki-67), apoptosis (terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling, TUNEL), and microvascular density (CD31+) were assessed in a validation cohort of n = 24 animals for time-matched ex vivo validation. Results An increase in tumor volume was observed in both groups (p ≤ 0.004) without difference at follow-up (p = 0.630). A lower ADC value was observed in the immunotherapy group at follow-up (p = 0.001). Immunohistochemistry revealed higher TUNEL values (p < 0.001) and CD8+ TILs (p = 0.048) following immunotherapy, as well as lower tumor cell Ki-67 values (p < 0.001) and microvascular density/CD31+ (p < 0.001). Conclusion Lower tumor ADC, paired with higher intratumoral expression of CD8+ TIL, was observed five days after immunotherapy, suggestive of early immunological response. Ex vivo immunohistochemistry confirmed the antitumoral efficacy of immunotherapy. Relevance statement Compared to tumor size, diffusion-weighted MRI demonstrated potential for early response assessment to immunotherapy in a murine melanoma model, which could reflect changes in the tumor microenvironment and immune cell infiltration. Key Points No difference in tumor volume was observed between groups before and after therapy. Lower ADC values paired with increased CD8+ TILs were observed following immunotherapy. Ex vivo immunohistochemistry confirmed antitumoral efficacy of anti-PD-L1 and anti-CTLA-4 immunotherapy. Graphical Abstracthttps://doi.org/10.1186/s41747-025-00597-8ImmunotherapyMelanomaMice (inbred C57BL)Multiparametric magnetic resonance imagingTumor microenvironment |
| spellingShingle | Maurice M. Heimer Amra Cimic Sandra Kloiber-Langhorst Melissa J. Antons Jennifer Stueckl Heidrun Hirner-Eppeneder Wolfgang G. Kunz Olaf Dietrich Jens Ricke Felix L. Herr Clemens C. Cyran Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI European Radiology Experimental Immunotherapy Melanoma Mice (inbred C57BL) Multiparametric magnetic resonance imaging Tumor microenvironment |
| title | Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI |
| title_full | Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI |
| title_fullStr | Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI |
| title_full_unstemmed | Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI |
| title_short | Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI |
| title_sort | quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric mri |
| topic | Immunotherapy Melanoma Mice (inbred C57BL) Multiparametric magnetic resonance imaging Tumor microenvironment |
| url | https://doi.org/10.1186/s41747-025-00597-8 |
| work_keys_str_mv | AT mauricemheimer quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT amracimic quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT sandrakloiberlanghorst quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT melissajantons quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT jenniferstueckl quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT heidrunhirnereppeneder quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT wolfganggkunz quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT olafdietrich quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT jensricke quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT felixlherr quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri AT clemensccyran quantitativeresponseassessmentofcombinedimmunotherapyinamurinemelanomamodelusingmultiparametricmri |